The best soundbites from our experienced thought leaders.
The old pharmacy benefits model is under fire – so what can employers look for it its place?…
According to SHRM, employers have reason to be anxious: “New projections find that inflation, GLP-1 drugs, and catastrophic…
A recent study found that one in five adults said they haven’t filled a prescription because of the…
In this extensive and thoughtful Q&A in BenefitsPRO, our SVP, Payer Solutions, Rae McMahan discusses the current state…
With the 2025 RFP season here, now is the perfect time to reflect on the impact and effectiveness…
The legacy PBM model is no longer sustainable. But the good news is that pharma and other healthcare…
A recent report by Pharmaceutical Strategies Group (PSG), sponsored by Prescryptive, spotlighted red hot GLP-1s and how employers…
“Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Drug Benefit Design Report, sponsored by Prescryptive Health, detailing the…
What can one fine at one store tell us? The prescription drug industry is at a breaking point.…
Employers may be hearing rumblings that it’s time to move on from the legacy PBMs in light of…
The days of paper prescriptions — when a patient got a piece of paper to carry from the…